Brown & Brown (BRO) is back in focus after the company disclosed that Executive Vice President and former Retail Segment President P. Barrett Brown resigned from all officer and director roles on August 10, 2026.

The resignation comes as Brown & Brown trades at US$70.54, with the share price returning 20.19% over the past 90 days, while the 1-year total shareholder return has declined 25.30%. This suggests that recent momentum has picked up after a weaker spell for long-term holders.

If this management change has you reassessing your watchlist, it could be a useful moment to widen your search and check out 21 top founder-led companies

Brown & Brown now trades below both its analyst price target and an estimate of intrinsic value after that sharp 90 day rebound. Is this a justified discount for the risks, or has caution gone too far?

Most Popular Narrative: 6.7% Undervalued

Brown & Brown's most followed narrative points to a fair value of $75.63 per share compared with the last close at $70.54, which frames the stock as modestly undervalued after recent price volatility.

Brown & Brown's strategic focus on acquisitions, having completed 13 acquisitions with projected annual revenues of $36 million, could significantly enhance future revenue streams and market presence. This aligns with their goal of sustained revenue growth through expansion.

Curious what sits behind that valuation gap for Brown & Brown. The narrative leans heavily on measured revenue growth, slightly thinner margins, and a richer future earnings multiple. The exact mix of those moving parts is where the story gets interesting.

Result: Fair Value of $75.63 (UNDERVALUED)

However, Brown & Brown's story could look very different if economic or legislative changes slow revenue growth, or if lower CAT property and flood related income squeeze margins.

Another View on Brown & Brown's Valuation

While the prevailing Brown & Brown narrative leans on discounted cash flows and a 6.7% discount to an estimated fair value of $75.63, the market price also embeds a richer earnings multiple. Brown & Brown trades on a P/E of 19.8x, compared with a fair ratio of 13.3x and an 11.5x average for the US Insurance industry.

That means investors today are paying a clear premium to both the fair ratio and the broader industry, even though the stock screens as undervalued against a DCF based estimate of future cash flows. The key question is which reference point you trust more for Brown & Brown: the cash flow model, or the earnings multiple that peers trade on.

For a closer look at how this earnings based view stacks up against peers and the fair ratio, our valuation breakdown sets out the numbers in full See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With Brown & Brown carrying both potential upsides and clear concerns, this is a good moment to act quickly and weigh the full picture for yourself. To compare the positives against the red flags in one place, review the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Brown & Brown?

Do not stop at Brown & Brown. Broaden your watchlist now with fresh stock ideas so you are not chasing opportunities after they have already moved.

• Spot potential growth stories early by scanning 20 elite penny stocks with strong financials that already show stronger financial foundations than many tiny peers.
• Zero in on quality at a discount by reviewing the 52 high quality undervalued stocks that combine solid fundamentals with prices that still look reasonable.
• Prioritize resilience and focus on 80 resilient stocks with low risk scores that carry more measured risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.